Maybe a letdown - or at least a left turn - was inevitable. A week after Elim Chan made her high-impact debut as music director designate of the San Francisco Symphony, Chinese New Zealand guest ...

Add Yahoo as a preferred source to see more of our stories on Google. Tianyi Lu conducting the San Francisco Symphony on Friday, June 12, 2026. (Brandon Patoc/San Francisco Symphony) Maybe a letdown - ...

Researchers are at a loss for why people across cultures and ages, regardless of their dominant hand, have a natural bias toward wandering in a counterclockwise direction. By Rachel Nuwer Iñaki ...

This Pew Research Center study goes beyond Americans’ partisan attachments and vote choices to explore the values and attitudes that underlie the political landscape and the Republican and Democratic ...

As a mom of two boys who lived through the MeToo movement, I've long appreciated feminist author Camille Paglia's famous 1990 provocation: "If civilization had been left in female hands, we would ...

Defense lawyers for convicted activist short seller Andrew Left demanded a mistrial Friday, citing an unusual courtroom error that they say tainted the entire verdict ...

Nithya Raman wept as she fell into third place Tuesday night behind Spencer Pratt and Karen Bass in the Los Angeles mayoral race. The socialist's face scrunched and her eyes watered as the results ...

On the eve of the 250th anniversary of the nation’s independence, more Americans on the right than on the left say they feel patriotic. Recent polls show that a majority of Democrats are “proud” of ...

A short-seller's uphill battle has become even steeper. Andrew Left, the famed short-seller and founder of Citron Research, was found guilty Monday in a Los Angeles court of 13 counts of securities ...

A federal judge blasted short-seller Andrew Left for being AWOL on Monday as the jury deliberated in his securities fraud trial — threatening to take him into custody if it happens again. The scolding ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...